Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort.

We observed a high prevalence of metabolic syndrome among patients with moderate CKD. Metabolic syndrome increases the risk for all-cause mortality and cardiovascular events. The glucose and lipid components seem to be the main drivers for the association with outcomes.